IU Health Bloomington

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Prostate cancer2 trials
• Multiple myeloma1 trial
• Obesity1 trial

Phase

• Phase 34 trials
• Phase 22 trials

Status

• Active, not recruiting3 trials
• Completed3 trials

Lead sponsor

• Alliance for Clinical Trials in Oncology1 trial
• ECOG-ACRIN Cancer Research Group1 trial
• National Cancer Institute (NCI)1 trial
• NRG Oncology1 trial
• Radiation Therapy Oncology Group1 trial
• and 1 more

Running trials

• Active, not recruiting

  Breast Cancer WEight Loss Study (BWEL Study)

  NCT02750826· Phase 3· Alliance for Clinical Trials in Oncology· Source

• Active, not recruiting

  Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

  NCT01863550· Phase 3· ECOG-ACRIN Cancer Research Group· Source

• Active, not recruiting

  Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

  NCT01708954· Phase 2· National Cancer Institute (NCI)· Source

Closed trials

• Completed

  Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer

  NCT02186847· Phase 2· NRG Oncology· Source

• Completed

  S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer

  NCT01809691· Phase 3· SWOG Cancer Research Network· Source

• Completed

  Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

  NCT00936390· Phase 3· Radiation Therapy Oncology Group· Source